Severe immune mucositis and esophagitis in metastatic squamous carcinoma of the larynx associated with pembrolizumab

ConclusionThis is the first described case of grade 4 immune mucositis and esophagitis associated with pembrolizumab. Because the use of pembrolizumab is increasing in oncology, pharmacists and physicians should be aware of this rare manifestation.
Source: Journal for Immunotherapy of Cancer - Category: Cancer & Oncology Source Type: research